Nanette Santoro, MD, knew she wanted to be a doctor at age 16, feeling like it was the best way to help people, something that would be good for mankind. The Endocrine Society is pleased to welcome Santoro, of the University of Colorado School of Medicine in Aurora, Colo., as its 2026 – 2027 president....
During ENDO 2026 in Chicago, the Endocrine Society will release its latest treatment recommendations, “Central Precocious Puberty: An Endocrine Society Clinical Practice Guideline.” Attendees are encouraged to arrive early at Room W375C at McCormick Place on Saturday June 13 at 4:30 p.m., for this highly anticipated session. At ENDO 2025 in San Francisco, researchers...
Some subgroups of children with precocious puberty — such as older girls with slowly progressing puberty—may not need the same level of testing or treatment, according to a new Endocrine Society Clinical Practice Guideline released today. “Children who start puberty earlier than usual should be carefully evaluated so they receive the right care at the right time—without...
Discover the latest advances in hormone research and clinical endocrinology at ENDO 2026. This year’s conference, taking place in Chicago, Ill., June 13-16, 2026, is designed to enhance your knowledge and skills in endocrinology with a mix of programs for both the clinician and researcher. With an extensive program covering a broad array of topics,...
Whether to treat low testosterone in men with obesity will be the topic of “Low Testosterone in Obesity: Should We Treat or Not?” a debate session at ENDO 2026 that is sure to be somewhat vigorous as two experts in the field take sides in a session moderated by Endocrine Society Past-President Stephen Hammes, MD,...
The Endocrine Society and Keystone Symposia are partnering to hold a series of joint translation scientific meetings that connect foundational (or basic) science with clinical practice across oncology, cardiometabolism, and diabetes with the aim of supporting a full bench-to-bedside and back research cycle. Keystone Symposia contributes deep connections to basic scientists and a robust infrastructure...
How the Endocrine Society’s Corporate Liaison Board fosters collaboration, fuels innovation, and advances patient care The Endocrine Society (the Society) strives to foster an interdisciplinary community of those practicing, researching, and innovating in endocrinology. Industry is an important site of innovation in endocrinology, and the Society’s Corporate Liaison Board (CLB) plays a pivotal role in...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Exelixis’ CABOMETYX Showed Positive Results Treating NET in Recent Trial On May 30, Exelixis, Inc., announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYX® (cabozantinib) provided significant improvements in progression-free survival (PFS) versus placebo...
During ENDO 2026 in Chicago, the Endocrine Society will release its latest treatment recommendations, “Central Precocious Puberty: An Endocrine Society Clinical Practice Guideline.” Attendees are encouraged to arrive early at Room W375C at McCormick Place on Saturday June 13 at 4:30 p.m., for this highly anticipated session. At ENDO 2025 in San Francisco, researchers...
